Calendar Magenta Therapeutics

Equities

MGTA

US55910K1088

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
30.6 USD -2.92% Intraday chart for Magenta Therapeutics +12.92% +173.37%

Chart calendar Magenta Therapeutics

52287b6a35959ca1daab5d.NVeFDb5ntOCx4eu9YBHqeBx6Bql_X3aMp8kpQcbc7Zs.VD79as8o5aOGh5rMIUbdDUoCQMBMHDXZ-K9bO6SWha9ZNcp8_DDErNeCvg~d8144c7e01f50729be3b70f84f05d423

Upcoming events on Magenta Therapeutics

No events available

Past events on Magenta Therapeutics

2023-05-03 08:30 am Magenta Therapeutics and Dianthus Therapeutics Merger Call
2022-12-13 08:30 am American Society of Hematology Meeting
2022-12-12 American Society of Hematology Meeting - The Pharmacokinetic and Pharmacodynamic
2022-12-12 American Society of Hematology Meeting - A Phase 2 Open-Label Study
2022-12-12 04:30 pm American Society of Hematology Meeting - Antibody-Drug Conjugated with Amanitin
2022-12-11 05:30 pm American Society of Hematology Meeting - Targeted Deletion of Activated
2022-11-08 11:00 am Credit Suisse Healthcare Conference
2022-11-03 09:01 am Q3 2022 Earnings Release
2022-08-09 09:45 am Wedbush PacGrow Healthcare Conference - Panel
2022-08-07 BTIG Biotechnology Conference
2022-08-04 08:00 am Interim 2022 Earnings Release
2022-06-28 09:00 am Annual General Meeting
2022-05-16 08:00 am Q1 2022 Earnings Release
2022-04-25 Transplantation & Cellular Therapy Meeting
2022-03-21 European Society of Blood and Marrow Transplantation Conference - Poster No: P688
2022-03-21 European Society of Blood and Marrow Transplantation Conference - Poster No: P689
2022-03-09 09:10 am Cowen & Co. Health Care Conference - Panel
2022-03-08 08:00 am FY 2021 Earnings Release
2022-01-28 11:00 am B. Riley Securities Virtual Oncology Conference
2022-01-13 09:45 am J.P. Morgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Million USD
Released
Forecast
Spread
-59,1
-56,7
-4.18%
-81,1
-81,7
0.67%
-76,7
-79,8
3.81%
-72,7
-72,9
0.38%
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-60,0
-57,9
-3.62%
-83,0
-82,4
-0.67%
-78,7
-79,5
1.06%
-74,7
-74,3
-0.51%
-80,9
-76,1
-6.32%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-57,5
-56,6
-1.65%
-76,8
-76,7
-0.11%
-74,9
-76,9
2.59%
-71,1
-71,7
0.84%
-76,5
-73,9
-3.46%
Net income
Million USD
Released
Forecast
Spread
-57,5
-56,6
-1.65%
-76,8
-76,8
0.02%
-74,9
-76,2
1.68%
-71,1
-69,9
-1.8%
-76,5
-72,6
-5.25%
EPS
USD
Released
Forecast
Spread
-50,1
-63,2
20.74%
-33,1
-33,0
-0.22%
-27,4
-27,8
1.72%
-20,6
-20,2
-2.27%
-20,6
-19,6
-5.16%
Announcement Date19/03/1903/03/2003/03/2108/03/2223/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Million USD
Released
Forecast
Spread
-17,1
-21,0
18.42%
-17,7
-20,0
11.44%
-19,6
-19,0
-3.18%
-23,3
-18,0
-29.57%















EBIT
Million USD
Released
Forecast
Spread
-17,6
-20,4
13.8%
-18,2
-19,7
7.51%
-20,1
-19,8
-1.53%
-23,8
-19,4
-22.75%
-18,1
-20,7
12.45%
-17,3
-18,1
4.57%
-21,7
-16,9
-28.43%
-32,1
-25,4
-26.37%
-7,38
-11,7
37.19%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-16,9
-19,8
14.29%
-17,4
-19,1
8.76%
-19,3
-18,9
-2.03%
-23,0
-18,7
-22.7%
-17,3
-19,2
10.16%
-16,1
-17,8
9.6%
-20,2
-17,6
-14.53%
-29,2
-24,9
-17.05%
-3,28
-11,4
71.14%
Net income
Million USD
Released
Forecast
Spread
-16,9
-19,5
13.38%
-17,4
-18,8
7.18%
-19,3
-19,0
-1.76%
-23,0
-19,3
-18.77%
-17,3
-20,5
15.74%
-16,1
-17,8
9.6%
-20,2
-16,4
-23.31%
-29,2
-24,9
-17.05%
-3,28
-11,4
71.14%
EPS
USD
Released
Forecast
Spread
-5,12
-5,90
13.25%
-4,80
-5,26
8.79%
-5,12
-5,15
0.6%
-6,24
-5,31
-17.46%
-4,64
-5,60
17.14%
-4,32
-4,85
10.99%
-5,44
-4,32
-25.93%
-7,68
-6,56
-17.07%
-0,80
-3,04
73.68%
Announcement Date05/08/2104/11/2108/03/2216/05/2204/08/2203/11/2223/03/2315/05/2303/08/23